Oncology Today with Dr Neil Love: Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer

Oncology Today with Dr Neil Love: Overcoming ...

Up next

Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Dr Aditya Bardia from the University of California Los Angeles and Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding the use of oral SERDs in the management of breast cancer. CME information and select publicati ...  Show more

HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making

Dr Seth Wander from Massachusetts General Hospital in Boston discusses the role of biomarker assessment in the management of HR-positive metastatic breast cancer. CME information and select publications here. 

Recommended Episodes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
Gynecologic Oncology Update

Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers. 

Recent Developments in Women's Health Research at the NIH
JAMA Clinical Reviews

NIH'S policies, programs, and research funding fill gaps in knowledge about women's health. Janine Austin Clayton, MD, of the NIH joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss key programs, policies, and scientific advances of the NIH that have i ...

  Show more

How Are ADCs Shifting the Way We're Practicing in TNBC?
Medscape InDiscussion: Triple-Negative Breast Cancer

Join experts Drs Kevin Kalinsky and Aditya Bardia as they discuss utilizing antibody-drug conjugates in clinic. What is currently available? What are the possible side effects? Tune in to find out. Relevant disclosures can be found with the episode show notes on Medscape (https:/ ...  Show more

Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
BackTable Urology

Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ...  Show more